Skip to main content

Table 1 Clinical and densitometric characteristics of the patients with systemic sclerosis and controls

From: Are the clinical phenotypes of systemic sclerosis determinant for osteoporosis and fragility fractures?

 

Systemic sclerosis (N = 84)

Controls (N = 80)

Gender (F/M)

77/7

66/14

Age (yrs)

64.5 ± 13.7

63.1 ± 10.8

BMI (Kg/m2)

24.5 ± 5.2

26.4 ± 3.4*

Menopause (years)

52.1 ± 2.8

53.1 ± 3.1

LS-BMD (g/cm2)

0.960 ± 0.168

1.090 ± 0.117**

LS T-score

-1.4 ± 1.3

-0.8 ± 0.9*

FN-BMD (g/cm2)

0.759 ± 0.121

0.857 ± 0.111*

FN T-score

-1.6 ± 1.0

-1.1 ± 0.8*

TH-BMD (g/cm2)

0.820 ± 0.114

0.943 ± 0.124**

TH T-score

-1.5 ± 1.1

-0.7 ± 0.9**

  1. Abbreviations F: female; M: male; BMI: body mass index; LS-BMD: bone mineral density at lumbar spine; FN-BMD: bone mineral density at femoral neck; TH-BMD: bone mineral density at total hip
  2. *p < 0.05; **p < 0.01 Systemic Sclerosis vs. Controls
Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us